Omicron remains dominant COVID variant – DOH | Inquirer

Omicron remains dominant COVID variant – DOH

/ 05:25 AM March 23, 2022

Omicron cases in Zamboanga

stock photo

MANILA, Philippines — The Omicron variant of COVID-19 remains the most dominant strain in the country based on samples that underwent genome sequencing, according to (DOH) Undersecretary Maria Rosario Vergeire.

Results of the latest genome sequencing run showed that 85.9 percent of the 568 samples nationwide tested positive for the Omicron variant from Jan. 1 to March 18. Only 0.18 percent or just one was positive for the Delta variant from the same batch of samples.

Article continues after this advertisement

The government declared the more transmissible Omicron as the dominant variant in January this year, when the country saw another surge in COVID-19 infections. It replaced the Delta strain, which caused a previous surge in September last year.

FEATURED STORIES

Two sublineages of Omicron—BA.1 and BA.2—named variants of concern by the World Health Organization (WHO), had been detected in the country from samples of infected persons.

Meanwhile, Vergeire reported that average daily reported cases from March 15 to March 21 were at 490, lower by 13 percent from the previous week.

Article continues after this advertisement

All regions remain at minimal risk classification and health-care systems capacity continue to be at low risk despite the apparent “plateauing” of case decline, she said.

Article continues after this advertisement

‘Manageable’

“These numbers are expected … and they’re manageable so we don’t have to worry about a slowdown [of case decline] because the numbers are low already,” she said at a press briefing on Tuesday.

Article continues after this advertisement

Vergeire also said the Philippines was not yet at an “endemic” stage, saying that there were certain indicators before the country can reach that point.

“We will reach that point when we can say that we have reached the endemic stage: Once we are at the lowest level of transmission state, when we have an adequate and appropriate immunity for the population and number of deaths as well as severe and critical infections in society are already acceptable,” Vergeire said.

Article continues after this advertisement

For infectious disease expert Edsel Salvana, signs of a transition to endemicity, such as the availability of COVID-19 treatments and vaccines that prevent hospitals from being overwhelmed, are already present.

Meanwhile, President Duterte on Monday said that he was not willing to lift the masking mandate despite the continuing decline of COVID-19 cases the country.

“About this mask … it has done a lot of good that prevented the contamination from spreading. So this [wearing of masks] will take a long time,” he said in his weekly “Talk to the People” public address aired on state television.

New variants

The President expressed concern that new variants from other countries might reach the Philippines and cause surges. He mentioned the new variant discovered in Israel which, health authorities reported, appeared to be a combination of the two subvariants of the Omicron variants.

Health Secretary Francisco Duque III, for his part, said “disciplined” and “consistent” compliance with minimum public health standards was one of the top reasons why COVID-19 cases remain low in the Philippines.

RELATED STORIES

AstraZeneca COVID-19 drug neutralizes Omicron sub-variants in lab study

PH has overcome Omicron threat of COVID-19 – Galvez

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

In endemic state, every Filipino will eventually get Omicron, says OCTA fellow

EDITORS' PICK
globalnation
sports
business
usa
sports
globalnation
www
www
business
globalnation
entertainment
TAGS: COVID-19 Omicron variant, DoH

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.